Skip to main content

Month: June 2024

Cabka announces 1 August 2024 EGM Agenda

Cabka announces 1 August 2024 EGM Agenda Amsterdam 20 June 2024. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, invites its shareholders to attend the Company’s extraordinary general meeting (the “General Meeting”), to be held on Thursday 1 August 2024 at 14:00 CEST. The Company looks forward to welcoming its shareholders both in-person and virtual at John M. Keynesplein 10, 1066 EP Amsterdam, the Netherlands. Registration for admission to the General Meeting starts at 13:00 CEST. The language of the General Meeting shall be English. AGENDAOpening Appointment of managing director (voting item) Amendment of the remuneration policy of the management board (voting...

Continue reading

Acquires Wonderway to AI-power its Sales Performance Solutions

P R E S S  R E L E A S E Stockholm, June 20, 2024 STOCKHOLM, SWEDEN – BTS GROUP (publ.), a leading global strategy implementation firm, has agreed to acquire the business, operations, and assets, notably the intellectual property and technologies, of Wonderway GmbH. Wonderway is a pioneering early-stage startup specializing in AI-powered sales performance SaaS products headquartered in Berlin, Germany. Wonderway’s flagship AI sales coach product turns every client sales meeting into practice. The AI sales coach uses its proprietary Sales-led Intelligence Coaching Engine (S.L.I.C.E) to automatically score sales calls, provide objective, targeted coaching in real-time, and deliver ongoing data-driven insights to sales executives. It helps organizations enhance their performance across sales teams and change behavior to align with the company’s...

Continue reading

Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and Nutrition

Press Release – Paris, June 20, 2024 Danone opens the next chapter of its Renew strategyProjecting the company into the future of Health and Nutrition Today, Danone is hosting a Capital Market Event where the company will share its mid-term strategy and value creation journey for the 2025-2028 period. Danone’s next chapter will build on the fundamentals the company reestablished over the last 2 years: science and innovation, operational and executional discipline, and proactive portfolio management. Danone will project itself into the future of Health and Nutrition by:Gradually pivoting the way it addresses its categories – notably Protein and Gut Health; Broadening some of its business models, accelerating in Away-from-home and Medical Nutrition; Further expanding its geographic footprint.Antoine de Saint-Affrique, Chief Executive...

Continue reading

Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order

                  Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order Meudon, France, 20 June 2024 – Vallourec has signed with the National Oil Company of Abu Dhabi a two-year extension to the 2019 contract originally worth c. 900MUSD. This extension will take effect in January 2025 and will last up to January 2027. Vallourec will continue to supply the complete range of tubes and connections for both conventional and complex applications in onshore and offshore Oil and Gas fields. In addition to the extension, the contract has been amended to expand the initial contract scope of supply to also include a new range of services, such as local pipe coating as well as Vallourec’s new digital solutions such as Tallyvision, which streamlines...

Continue reading

SkiStar AB Interim Report September 2023-May 2024

GREAT INTEREST IN SCANDINAVIAN MOUNTAIN HOLIDAYS Third QuarterNet sales for the third quarter increased by SEK 81 million, 6 percent, to SEK 1,490 million (1,409). Operating profit increased by SEK 65 million, 18 percent, to SEK 418 million (353). Capital gains from exploitation operations were included with SEK -3 million (1). Cash flow from operating activities decreased by SEK 32 million to SEK -268 million (-236). Basic and diluted earnings per share amounted to SEK 3.99 (3.43), an increase of 16 percent.First Nine MonthsNet sales for the nine-months period increased by SEK 404 million, 10 percent, to SEK 4,340 million (3,936). Operating profit increased by SEK 184 million, 22 percent, to SEK 1,019 million (834). Capital gains from exploitation operations were included with SEK -10 million (12). Cash flow from operating activities...

Continue reading

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation

Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset purchase agreement with the Glioblastoma Foundation Inc., for Basilea’s oncology drug candidate lisavanbulin (BAL101553), which has been developed as a potential therapy for glioblastoma, the most common type of primary brain cancer.1 Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “Glioblastoma is one of the most lethal types of brain cancer and available therapeutic options are very limited. Partnering lisavanbulin with the Glioblastoma Foundation is important to us, as it enables patients to continue having access to this promising anticancer drug candidate,...

Continue reading

Update on license renewals in Canada West (British Columbia)

Yesterday evening the Government of Canada announced a new 5 year licensing period to 30 June 2029 as well as a policy to move-away from traditional marine salmon farms in the province of British Columbia. The government proposes to move BC salmon farms to closed-containment systems or onto land. Further details including a draft plan for the required transition are to be announced by the end of July 2024 and will be followed by another period of consultation. The unfortunate announcement comes despite our efforts to pave the way for future sustainable growth and employment, including a thorough consultation process involving multiple stakeholders as well as gaining strong support over the years from the local communities in which we operate. We are disappointed with the decision since traditional marine salmon farming is absolutely sustainable,...

Continue reading

Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting

OSLO, Norway, June 20, 2024 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced advancements in its inverse vaccine platform at the annual Federation of Clinical Immunology Societies (FOCIS) meeting in San Francisco. Building on findings previously announced in March at the Antigen-Specific Immune Tolerance Summit in Boston, Nykode presented extended therapeutic data from the experimental autoimmune encephalomyelitis (EAE) model of Multiple Sclerosis (MS). The updates included demonstrating the disease-modifying effects of two distinct targeting units within its inverse vaccine platform in a therapeutic regimen, highlighting the versatility and effectiveness of antigen-presenting cell (APC)-targeting...

Continue reading

Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation

Press ReleaseVELIZY-VILLACOUBLAY, France — June 20, 2024 Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital TransformationAutomotive leader in India makes strategic decision to use Dassault Systèmes’ 3DEXPERIENCE platform on the cloud for its end-to-end new product development process Mahindra & Mahindra can improve efficiency, reduce time to market, and support its sustainability goals for their automotive business The 3DEXPERIENCE platform on the cloud will be utilized for all future auto programs of Mahindra & MahindraDassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Mahindra & Mahindra, a leader in automotive, farm and services businesses in India, is advancing its digital transformation by selecting Dassault Systèmes’...

Continue reading

GPS Capital Markets Enters into Agreement to be Acquired by Corpay

GPS Capital Markets and CorpayAcquisition between Corporate FX and Global Corporate Payment LeadersSALT LAKE CITY, June 19, 2024 (GLOBE NEWSWIRE) — GPS Capital Markets, LLC, a leading fintech firm offering corporate foreign exchange services, announced entering into a definitive agreement to be acquired by Corpay, Inc. (NYSE: CPAY), a leading corporate payments company. This acquisition will bring tremendous benefits to GPS Capital Markets clients, including enhanced delivery channels and expanded access to FX services across global markets. “At GPS our clients are at the heart of everything we do. With Corpay‘s resources and our team’s expertise, we are poised to provide even greater value and drive transformative outcomes in the financial markets. The combined capabilities of our two companies will significantly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.